NHFT Contraceptives Formulary January 2017

Size: px
Start display at page:

Download "NHFT Contraceptives Formulary January 2017"

Transcription

1 NHFT Contraceptives Formulary January 201 Contents Contraceptives... 2 Combined hormonal contraceptives... 2 Progestogen-only contraceptives... 2 Contraceptve devices... 3 Emergency Contraception... 3 Table of Oral Contraceptive Preparations December Page 1 of 6

2 Contraceptives Combined hormonal contraceptives Oral preparations - See table below (sections 1-) Transdermal (Standard strength) with norelgestromin patches (Evra ) Vaginal (low strength) with Etonogestrel (NuvaRing ) Progestogen-only contraceptives Oral progestogen-only contraceptives See table below (section 8) Parenteral progestogen-only contraceptives Injectable preparations Medroxyprogesterone acetate 10mg in 1ml pre-filled syringe (Depo-Provera ) Medroxyprogesterone acetate 104mg in 0.6ml pre-filled injector device (Sayana Press ) enantate 200mg/ml oily injection (Noristerat ) Implants Etonogestrel 68mg flexible rod (Nexplanon ) Intra-uterine progestogen-only device 2mg device (Mirena ) 13.mg device (Jaydess ) Page 2 of 6

3 Contraceptve devices Intra-uterine contraceptive devices T-safe Cu 380A T-Safe Cu 380A (QL) QuickLoad Emergency Contraception 1.mg tablet Levonelle One Step Levonelle 100 Ulipristal acetate 30mg tablet (ellaone ) Intra-uterine device (see previous) Page 3 of 6

4 Table of Oral Contraceptive Preparations December 2016 Type of preparation (1)Monophasic low strength (-day (2)Monophasic standard strength (-day (3)Monophasic standard strength (28-day Every day Oestrogen 20 micrograms 20 micrograms 20 micrograms Mestranol 0 micrograms Progestogen Desogestrel 10 micrograms acetate 1 mg Desogestrel 10 micrograms Tablets per cycle Equivalent Brands Gedarel 20/10 Lestramyl 20/10 Mercilon Munalea 20/10 Aidulan 20/ Femodette Millinette 20/ Sunya 20/ Loestrin 20 Drospirenone 3 mg 10 micrograms acetate 1. mg Norgestimate 20 micrograms Alenova Cimizt Gedarel 30/10 Lestramyl 30/10 Marvelon Munalea 30/10 Cleosensa Lucette Yasmin Aidulan 30/ Femodene Katya 30/ Millinette 30/ Elevin Erlibelle Maexeni Levest Microgynon 30 Ovranette Rigevidon Loestrin 30 Cilest Lizinna Brevinor Ovysmen 1 mg Norimin 1 mg Norinyl-1 10 micrograms active & inactive active & inactive Femodene ED Microgynon 30 ED Page 4 of 6

5 Type of preparation Oestrogen Progestogen Tablets per cycle Equivalent Brands (4)Monophasic (28- day Every day preparation) Estradiol (as hemihydrate) 1. mg Nomegestrol acetate 2. mg 24 active & 4 inactive Zoely 0 micrograms 6 40 micrograms 0 micrograms Triadene 100 micrograms 10 0 micrograms 6 40 micrograms Logynon TriRegol 12 micrograms 10 ()Phasic standard strength (-day 1 mg 14 BiNovum 1 mg 9 Synphase 0 micrograms TriNovum 1 mg 0 micrograms 6 (6)Phasic standard strength (28-day Every day preparation) 40 micrograms 12 micrograms 10 Logynon ED inactive Page of 6

6 Type of preparation Oestrogen Progestogen Tablets per cycle Equivalent Brands 3 mg Dienogest 2 mg 2 ()Phasic (28-day Every day preparation) 2 mg 2 mg 1 mg Dienogest 3 mg 1 2 Qlaira 2 inactive 28 Aizea 28 Cerazette 28 Cerelle Desogestrel 28 Desomono 28 Desorex (8) Progesterone Only 28 Feanolla 28 Nacrez 28 Zelleta 30 micrograms 3 Norgeston 30 micrograms 28 Micronor 28 Noriday Page 6 of 6

Hormonal contraception: NHS Tayside Formulary, pharmacological content and other characteristics

Hormonal contraception: NHS Tayside Formulary, pharmacological content and other characteristics Hormonal contraception: NHS Tayside Formulary, pharmacological content and other characteristics Advice from the Tayside Sexual & Reproductive Health Service (TSRHS) (Last update: 10/2017) Combined hormonal

More information

SCOTTISH DRUG TARIFF ANNEX B: PRESCRIPTION CHARGES

SCOTTISH DRUG TARIFF ANNEX B: PRESCRIPTION CHARGES SCOTTISH DRUG TARIFF PART 1 ANNEX B: PRESCRIPTION CHARGES From 1 st April 2011 the prescription charge in Scotland has been abolished. Any Scottish prescription form presented for dispensing in Scotland

More information

SCOTTISH DRUG TARIFF ANNEX B: PRESCRIPTION CHARGES

SCOTTISH DRUG TARIFF ANNEX B: PRESCRIPTION CHARGES SCOTTISH DRUG TARIFF PART 1 ANNEX B: PRESCRIPTION CHARGES From 1 st April 2011 the prescription charge in Scotland has been abolished. Any Scottish prescription form presented for dispensing in Scotland

More information

Bradford Contraception and Sexual Health Services FORMULARY

Bradford Contraception and Sexual Health Services FORMULARY Bradford Contraception and Sexual Health Services FORMULARY Medication Stock Item Strength Form Pack Size Indication Acetone Liquid 50ml For lab use Aciclovir TTO (PGD) 400mg Tablets 15 Herpes Treatment

More information

7: Obstetrics, gynaecology, and urinary tract disorders

7: Obstetrics, gynaecology, and urinary tract disorders Original Date of issue: 31/12/2005 Last eviewed: 11/11/2011 Version:4 Page 1 of 6 7: Obstetrics, gynaecology, and urinary tract disorders 7.1 Drugs used in obstetrics 7.1.1 Prostaglandins and oxytocics

More information

Infections of the genito-urinary system and sexually transmitted diseases Please refer to the Treatment of infections in Primary Care section

Infections of the genito-urinary system and sexually transmitted diseases Please refer to the Treatment of infections in Primary Care section Genito-urinary System Infections of the genito-urinary system and sexual transmitted diseases - Please refer to the Treatment of infections in Primary Care section Combined Hormonal Contraceptives Combined

More information

Volume 8; Number 7 April 2014

Volume 8; Number 7 April 2014 Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire

More information

SIDE EFFECT MANAGEMENT

SIDE EFFECT MANAGEMENT SIDE EFFECT MANAGEMENT SIDE EFFECT MANAGEMENT Side effects usually diminish within 3 months with continued use of same method 17 Reassure & educate patients to help establish realistic expectations & decrease

More information

Medications & Mothers Milk 2017

Medications & Mothers Milk 2017 See Monograph for Details Alesse, Aviane, Lessina, Levlite, Lutera, Sronyx Monophasic Ethinyl estradiol 20 mcg Levonorgestrel 0.1 mg Angeliq Monophasic Estradiol 1 mg Drospirenone 0.5 mg Approved in Europe

More information

Oral Contraceptives. Mike Williams GPST2

Oral Contraceptives. Mike Williams GPST2 Oral Contraceptives Mike Williams GPST2 Curriculum Mechanism Efficacy Advantages/Disadvantages Starting Continuing Problems/complications Contraception: effectiveness rates, risks, benefits and appropriate

More information

Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland

Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland Dr Audrey Brown Dr Alison Bigrigg Greater Glasgow and Clyde Long-acting reversible

More information

requesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group

requesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group July 2015 Our Ref: FOI.15.CAN0059 requesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group Could you please provide me with the details

More information

Beneficiary Advisory Panel Handout Uniform Formulary Decisions June 2006

Beneficiary Advisory Panel Handout Uniform Formulary Decisions June 2006 Beneficiary Advisory Panel Handout Uniform Formulary Decisions June 2006 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical-effectiveness

More information

requesting information regarding Referral target schemes for GPs in NHS Ashford Clinical Commissioning Group

requesting information regarding Referral target schemes for GPs in NHS Ashford Clinical Commissioning Group August 2015 Our Ref: FOI.15.ASH0102 requesting information regarding Referral target schemes for GPs in NHS Ashford Clinical Commissioning Group a) Does the CCG currently operate any schemes for GPs which

More information

Contraception and Kidney Problems: Advice for Young Adults

Contraception and Kidney Problems: Advice for Young Adults Contraception and Kidney Problems: Advice for Young Adults Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Oral Hormonal Contraceptive Agent Formulary Positioning: (Current as of 5/2017) Aviane Y F $ Orsythia Y F $ Falmina Y F $18.

Oral Hormonal Contraceptive Agent Formulary Positioning: (Current as of 5/2017) Aviane Y F $ Orsythia Y F $ Falmina Y F $18. MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Hormonal Contraception P&T DATE: 5/9/2017 CLASS: Endocrine REVIEW HISTORY 2/16 LOB: Medi-Cal (MONTH/YEAR) This policy has

More information

Article Title: Period Prevalence and Perceived Side Effects of Hormonal Contraceptive Use and the Menstrual Cycle in Elite Athletes

Article Title: Period Prevalence and Perceived Side Effects of Hormonal Contraceptive Use and the Menstrual Cycle in Elite Athletes Note. This article will be published in a forthcoming issue of the. The article appears here in its accepted, peer-reviewed form, as it was provided by the submitting author. It has not been copyedited,

More information

CONTRACEPTION AND MISCONCEPTIONS CONTRACEPTION IN WOMEN WITH MENTAL ILLNESS

CONTRACEPTION AND MISCONCEPTIONS CONTRACEPTION IN WOMEN WITH MENTAL ILLNESS CONTRACEPTION AND MISCONCEPTIONS CONTRACEPTION IN WOMEN WITH MENTAL ILLNESS OVERVIEW Hormones and mood How mental illness impacts on contraceptive choice Ideal contraception Pro and cons of contraceptive

More information

Preventive Services: Covered Contraceptive Products for Washington

Preventive Services: Covered Contraceptive Products for Washington PHARMACY SERVICES Preventive Services: Covered Contraceptive Products for Washington Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive

More information

Hormone Products for Postmenopausal Use in the United States and Canada

Hormone Products for Postmenopausal Use in the United States and Canada Hormone Products for Postmenopausal Use in the United States and Canada Copyright The North American Menopause Society October 25, 2011 Table 1. Oral ET products for postmenopausal use in the United States

More information

Management of Emergency Contraception (EC)

Management of Emergency Contraception (EC) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Management of Emergency Contraception (EC) The risks and benefits of an IUD or oral EC should be discussed and documented (see appendix). Reasonable measures

More information

REPRODUCTIVE HEALTH REPRODUCTIVE HEALTH

REPRODUCTIVE HEALTH REPRODUCTIVE HEALTH REPRODUTIVE HELTH REPRODUTIVE HELTH 147 B D F E G ondoms Lubricated LifeStyles Lubricated Premium ondoms Latex, 144/box. LifeStyles () 046361 Box LifeStyles Extra-Strength Lubricated ondoms Latex, extra-strength,

More information

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Contraception Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Disclosures No financial relationships to disclose I have no commercial, financial, research ties to

More information

Future methods of fertility regulation

Future methods of fertility regulation Future methods of fertility regulation Catherine d Arcangues, d Ph.D., M.D. Department of Reproductive Health and Research World Health Organization Training in Reproductive Health Research Geneva 2006

More information

Efficacy and side-effects of oral contraceptives

Efficacy and side-effects of oral contraceptives DRUG REVIEW Efficacy and side-effects of oral contraceptives ANNE MACGREGOR For the majority of women, oral contraception is safe, convenient and effective, but users should be counselled about potential

More information

One-day Essentials Contraception. Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire

One-day Essentials Contraception. Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire One-day Essentials Contraception { Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire 80% women access contraception from their GP Therefore it is

More information

D e p o p r o v e r a i n j e c t i o c a l e n d a r

D e p o p r o v e r a i n j e c t i o c a l e n d a r D e p o p r o v e r a i n j e c t i o c a l e n d a r 2 0 1 6 5-10-2016 Depression may be a potential adverse effect of hormonal birth control use, a new study suggests. The Depo - Provera shot is an injection

More information

Review Use of the new progestogens in contraception and gynaecology

Review Use of the new progestogens in contraception and gynaecology The Obstetrician & Gynaecologist 10.1576/toag.8.4.229.27272 www.rcog.org.uk/togonline 2006;8:229 234 Review Review Use of the new progestogens in contraception and gynaecology Author Diana Mansour Key

More information

REPRODUCTIVE HEALTH 159

REPRODUCTIVE HEALTH 159 REPRODUTIVE HEALTH 159 A E D F ondoms Lubricated LifeStyles Lubricated Premium ondoms Latex, 144/box. LifeStyles (A) 046361 ox LifeStyles Extra-Strength Lubricated ondoms Latex, extra-strength, 144/box.

More information

Progestogen only Contraception

Progestogen only Contraception Progestogen only Contraception Public Health Commissioned Service delivered by Community Pharmacies Jo Sutton Senior Commissioning Manager Long Term Care, Health and Treatment, Cheshire East Council Dr

More information

Clinical Challenges in Contraception. Disclosures. Objectives Pharmacists 4/3/2018

Clinical Challenges in Contraception. Disclosures. Objectives Pharmacists 4/3/2018 Clinical Challenges in Contraception Kathleen Besinque, PharmD Sarah McBane, PharmD Disclosures Kathleen Besinque has nothing to disclose Sarah McBane has nothing to disclose Objectives Pharmacists Compare

More information

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises

More information

Learning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available

Learning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available 8:45 9:30 am Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin

More information

Oral contraception in Denmark

Oral contraception in Denmark A C TA Obstetricia et Gynecologica AOGS MAIN RESEARCH ARTICLE Oral contraception in Denmark 1998 2010 NADIA M. WILSON 1, MAJA LAURSEN 2 & ØJVIND LIDEGAARD 1 1 Gynecological Clinic, Rigshospitalet University

More information

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Disclosure I am a Nexplanon trainer for Merck. Objectives Understand how obesity may affect pharmacokinetics

More information

Female sex steroids and contraceptives agents

Female sex steroids and contraceptives agents Female sex steroids and contraceptives agents Female Sex Hormones Sex hormones produced by the gonads are necessary for conception, embryonic maturation, and development of primary and secondary sexual

More information

Learning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available

Learning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available 2:15 3pm Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin Batur,

More information

LET S TALK PREVENTION

LET S TALK PREVENTION LET S TALK PREVENTION YOUR NO-COST PRESCRIPTION DRUGS FOR PREVENTIVE CARE Your health plan offers certain preventive service benefits at no cost to you. This means you don t have to pay a copay* or coinsurance,

More information

Trudy Bush Lecture: Using Progestins in Clinical Practice. Progestins in Clinical Practice: Outline. NAMS Definitions. FDA Approved Oral Progestins

Trudy Bush Lecture: Using Progestins in Clinical Practice. Progestins in Clinical Practice: Outline. NAMS Definitions. FDA Approved Oral Progestins 1 Women's Health 2015: The 23rd Annual Congress FRIDAY, April 17, 2015 Trudy Bush Lecture: Using Progestins in Clinical Practice Commercial Disclosure: I am a consultant on litigation relating to the Mirena

More information

Affordable Care Act Covered Contraceptive Products

Affordable Care Act Covered Contraceptive Products PHARMACY SERVICES Affordable Care Act Covered Contraceptive Products Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive care and

More information

Preventive Services: Covered Contraceptive Products for Oregon

Preventive Services: Covered Contraceptive Products for Oregon PHARMACY SERVICES Preventive Services: Covered Contraceptive Products for Oregon Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive

More information

Preventive Services: Covered Contraceptive Products for Utah

Preventive Services: Covered Contraceptive Products for Utah PHARMACY SERVICES Preventive Services: Covered Contraceptive Products for Utah Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive

More information

Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor

Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service

More information

WHAT ARE CONTRACEPTIVES?

WHAT ARE CONTRACEPTIVES? CONTRACEPTION WHAT ARE CONTRACEPTIVES? Methods used to prevent fertilization *Also referred to as birth control methods With contraceptives, it is important to look at what works for you and your body.

More information

Clinical Policy: Goserelin Acetate (Zoladex) Reference Number: ERX.SPA.145 Effective Date:

Clinical Policy: Goserelin Acetate (Zoladex) Reference Number: ERX.SPA.145 Effective Date: Clinical Policy: (Zoladex) Reference Number: ERX.SPA.145 Effective Date: 10.01.16 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

ISPUB.COM. Contraception: What s New? Literature Review. P Reshi OVERVIEW COMBINED ORAL CONTRACEPTIVES DROSPIRENONE

ISPUB.COM. Contraception: What s New? Literature Review. P Reshi OVERVIEW COMBINED ORAL CONTRACEPTIVES DROSPIRENONE ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 11 Number 1 P Reshi Citation P Reshi.. The Internet Journal of Gynecology and Obstetrics. 2008 Volume 11 Number 1. Abstract This article

More information

Contraceptive Technology Past, Present & Future

Contraceptive Technology Past, Present & Future ICCR 100 TH MEETING: 42 YEARS OF ACHIEVEMENT Contraceptive Technology Past, Present & Future Regine Sitruk-Ware, MD Population Council 20 April 2012 New York, NY USA The International Committee for Contraceptive

More information

Status Update on the National Cardiovascular Prevention Guidelines - JNC 8, ATP 4, and Obesity 2

Status Update on the National Cardiovascular Prevention Guidelines - JNC 8, ATP 4, and Obesity 2 TABLE OF CONTENTS Status Update on the National Cardiovascular Prevention Guidelines 1 Drosperinone-Containing Oral Contraceptives and Venous Thromboembolism Risk 1-4 P&T Committee Formulary Action 5 Status

More information

Reviewer No.2 Commentary: contraceptive medicines: does choice make a difference?

Reviewer No.2 Commentary: contraceptive medicines: does choice make a difference? Reviewer No.2 Commentary: contraceptive medicines: does choice make a difference? The detailed review by Andrew Gray and colleagues (Systematic review of contraceptive medicines: does choice make a difference?

More information

100% Highly effective No cost No side effects

100% Highly effective No cost No side effects effective? Advantages Disadvantages How do I get Cost Abstinence For some it can mean no sexual contact. For others it is no sexual intercourse or vaginal penetration. A permanent surgical procedure available

More information

Menopause. Medicines To Help You

Menopause. Medicines To Help You Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat

More information

Guidance on Bioequivalence Studies for Reproductive Health Medicines

Guidance on Bioequivalence Studies for Reproductive Health Medicines Guidance on Bioequivalence Studies for Reproductive Health 1 TABLE OF CONTENTS 1. Introduction... 3 2. Which products require a bioequivalence study?... 4 3. Design and conduct of bioequivalence studies...

More information

Topic 24: Estrogens and Female Reproductive Drugs

Topic 24: Estrogens and Female Reproductive Drugs Topic 24: Estrogens and Female Reproductive Drugs I. Contraceptives A. Estrogen-Progestin Contraceptives Note all of these drugs contain one estrogen (listed first) and one progestin Drug to know: ethinyl

More information

Appendix A Materials Considered by Dr. Shelley Tischkau In addition to the materials specifically referenced in my report, the other materials I have considered are: Literature Editorial: Sex Hormone Binding

More information

CODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40

CODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40 CODING GUIDELINES FOR CONTRACEPTIVES Effective June 1, 2017 Version 1.40 TABLE OF CONTENTS ICD-10 CM Diagnosis Codes: Encounter for Contraception page 2 Coding for IUD Insertion and Removal Procedures

More information

Long Acting Reversible Methods of Contraception (LARC) in Scotland

Long Acting Reversible Methods of Contraception (LARC) in Scotland Publication Report Long Acting Reversible Methods of Contraception (LARC) in Scotland Year ending March 2015 Publication date 3 November 2015 A National Statistics Publication for Scotland Contents Introduction...

More information

Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare

Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare New data A paper published in May 2012 in the British Medical Journal

More information

Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare

Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare Declaration of Competing Interests I have not received

More information

3.0 FORMULARY LIST FOR USE IN FAMILY PLANNING

3.0 FORMULARY LIST FOR USE IN FAMILY PLANNING 3.0 FORMULARY LIST FOR USE IN FAMILY PLANNING 2018 Provider Agreement Pharmacy Formulary NMDOH Family Planning Program Order questions: Joshua Rodriguez (505) 476-8350, Julie Roybal (505) 476-8362, or

More information

Volume 7; Number 17 October 2013

Volume 7; Number 17 October 2013 Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire

More information

Patient Group Direction for the administration of Levonorgestrel Emergency Contraception for Community Pharmacy

Patient Group Direction for the administration of Levonorgestrel Emergency Contraception for Community Pharmacy Patient Group Direction for the administration of Levonorgestrel for Community Pharmacy Author Corporate Lead Chris Toothill (Medicines Management Pharmacist, Governance and Risk, Leeds Community Healthcare

More information

Contraception in Primary Care: Helping Your Patients Choose the Best Method

Contraception in Primary Care: Helping Your Patients Choose the Best Method Friday CME Breakfast Contraception in Primary Care: Helping Your Patients Choose the Best Method Rebecca Hart, MD Family Physician, South Shore Medical Center Co Chair, 2017 Annual Session & Primary Care

More information

Instructions how to use the ESC teach the teachers course and self-learning tool

Instructions how to use the ESC teach the teachers course and self-learning tool Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually

More information

CLINICAL PEARLS IN CONTRACEPTION

CLINICAL PEARLS IN CONTRACEPTION CLINICAL PEARLS IN CONTRACEPTION Laura Borgelt, PharmD, FCCP, BCPS Associate Professor University of Colorado Denver PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as

More information

Table I. Examples of Hormone and Tapering Regimens

Table I. Examples of Hormone and Tapering Regimens Table I. Examples of Hormone and Tapering Regimens Severe AUB Heavy bleeding (soaking through 2 maxi pads an hour, 2 hours in a row) History of heavy menses Hemodynamically un (tachycardia, hypotensive,

More information

Instructions how to use the ESC teach the teachers course and self-learning tool

Instructions how to use the ESC teach the teachers course and self-learning tool Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually

More information

Estrogens and progestogens

Estrogens and progestogens Estrogens and progestogens Estradiol and Progesterone hormones produced by the gonads are necessary for: conception embryonic maturation development of primary and secondary sexual characteristics at puberty.

More information

Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition

Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists

More information

Medical Eligibility for Contraception Use

Medical Eligibility for Contraception Use Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist

More information

When talking about CHC it should not be forgotten that in addition to providing contraception this contraceptive method is associated with additional

When talking about CHC it should not be forgotten that in addition to providing contraception this contraceptive method is associated with additional 1 2 When talking about CHC it should not be forgotten that in addition to providing contraception this contraceptive method is associated with additional health benefits. These benefits can be used to

More information

Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be

Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be made with input from your healthcare provider. After the decision has been made to take HT, many women don t realize

More information

This document will be updated as required.

This document will be updated as required. This document will be updated as required. Last Update 27th May 2011 BNF CHAPTER 1 - GASTRO-INTESTINAL 1.1 Antacids (All available OTC) Co-Magaldrox - Low Na + - cheaper if prescribed as Mucogel Brand.

More information

Current approaches to managing heavy menstrual bleeding

Current approaches to managing heavy menstrual bleeding Drug review Heavy menstrual bleeding Current approaches to managing heavy menstrual bleeding Jasmine Tay BM BS, Shruti Mohan MRCOG and Jenny Higham FRCOG SPL The choice of drug treatment for heavy menstrual

More information

Facts on Contraception and Abortion

Facts on Contraception and Abortion Facts on Contraception and Abortion 1. Almost all modern contraceptives are in the World Health Organization's (WHO) Model List of Essential Medicines. The latest list of the WHO (2007, p. 109) include

More information

Taking provera with nexplanon

Taking provera with nexplanon Taking provera with nexplanon The Borg System is 100 % Taking provera with nexplanon Aug 31, 2015. Side effects for everyone are different, and the amount of time that it takes for your body to get used

More information

Focus on long-acting reversible contraception 2015

Focus on long-acting reversible contraception 2015 Focus on long-acting reversible contraception 2015 Anita Sheetz, CNM, is an employee at the Mesa County Health Department working in the family planning and STD clinic. She has no financial disclosures.

More information

CONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK

CONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK CONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK Global figures Women account for 51.6% of HIV globally (15.9m of 30.8m HIV+ adults) UNAIDS report on the global AIDS epidemic, 2010 Estimated no.

More information

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS II. Under 10 United States

More information

LARC. sample. ask brook about. Are any of them right for me? How effective is it? How long does it last? long acting reversible contraception

LARC. sample. ask brook about. Are any of them right for me? How effective is it? How long does it last? long acting reversible contraception 72888_LARC:Layout 1 9/11/09 11:47 Page 1 Are any of them right for me? ask brook about LARC How effective is it? long acting reversible contraception How long does it last? 72888_LARC:Layout 1 9/11/09

More information

Future methods of fertility regulation

Future methods of fertility regulation Future methods of fertility regulation Catherine d Arcangues, d Ph.D., M.D. Department of Reproductive Health and Research World Health Organization CDA/HUG/MARCH 04 Contraceptive use % married women 15

More information

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre AUB Outline Terminology Classification/Etiology Assessment Treatment Referral to Gynaecology U c pt 4

More information

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception

More information

What s New in Adolescent Contraception?

What s New in Adolescent Contraception? What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent

More information

What size needle for depo provera

What size needle for depo provera What size needle for depo provera The Borg System is 100 % What size needle for depo provera Jan 14, 2015. Nurse may administer Depo Provera in AIT, Same Day Clinic or by Nurse appointments. Equipment:

More information

MMPr001 EMERGENCY CONTRACEPTION PROTOCOL

MMPr001 EMERGENCY CONTRACEPTION PROTOCOL MMPr001 EMERGENCY CONTRACEPTION PROTOCOL MMPr001 Emergency Contraception - (Sept18-Sept20) Page 1 of 8 Table of Contents MMPr001 EMERGENCY CONTRACEPTION PROTOCOL... 1 Why we need this protocol... 3 What

More information

5. Summary of Data Reported and Evaluation

5. Summary of Data Reported and Evaluation 326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal

More information

QUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN

QUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN QUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN Why is new information being made available now? A recent Europe wide review looked at the benefits and risks of

More information

Teen Sexual Health Survey

Teen Sexual Health Survey Instructions Teen Sexual Health Survey Thank you for taking part in our survey. DO NOT write your name on this survey. The answers you give will be kept private. No one will know what you write. Answer

More information

Many women spend more than half of their approximately

Many women spend more than half of their approximately n clinical n Budget Impact Analysis of 8 Hormonal Contraceptive Options Simone Crespi, MPH; Matthew Kerrigan, PhD; and Vipan Sood, MBA, MRPharmS, RPh Many women spend more than half of their approximately

More information

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code 1074g, as implemented

More information

5. Summary of Data Reported and Evaluation

5. Summary of Data Reported and Evaluation 168 IARC MONOGRAPHS VOLUME 91 5. Summary of Data Reported and Evaluation 5.1 Exposure data The first oral hormonal contraceptives that were found to inhibit both ovulation and implantation were developed

More information

Power Point Use in EBPs. CAPP & PREP Learning Community May 15, 2018

Power Point Use in EBPs. CAPP & PREP Learning Community May 15, 2018 Power Point Use in EBPs CAPP & PREP Learning Community May 15, 2018 Objectives Best practices for power point use Why use power point for EBP delivery Examples: the Good, the Bad and the Ugly Recommendations

More information

Contraception for young people. Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015

Contraception for young people. Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015 Contraception for young people Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015 Learning objectives Be able to apply the principles of confidentiality, Fraser Guidelines, consent and safeguarding

More information

Choosing a Hormonal Contraceptive

Choosing a Hormonal Contraceptive PL Detail-Document #311001 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER October 2015 Choosing a Hormonal

More information

LEVONORGESTREL 1500 microgram tablets

LEVONORGESTREL 1500 microgram tablets Patient Group Direction for the supply of LEVONORGESTREL 1500 microgram tablets by Community Pharmacists Valid from: July 1 st 2014 Review: June 30 th 2015 Expiry date: June 30 th 2016 PGD Reference Number:

More information

Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science

Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy Describe extended cycle oral contraceptive characteristics including dosing regimen, indications,

More information

Malou Lindberg, Anniqa Foldemo, Ann Josefsson and Ann-Britt Wiréhn. Linköping University Post Print

Malou Lindberg, Anniqa Foldemo, Ann Josefsson and Ann-Britt Wiréhn. Linköping University Post Print Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: A nationwide population-based study with age-specific analyses Malou Lindberg,

More information

A Practitioner s Toolkit for the Management of the Menopause

A Practitioner s Toolkit for the Management of the Menopause Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash

More information

4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms

4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 550 4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 4.1 Absorption, distribution, metabolism and excretion 4.1.1 Humans The pharmacokinetics of the newer progestogens, desogestrel,

More information